Cancer Vaccine
Dendritic cells from peripheral blood monocytes exert enhanced antigen-presenting capacity
Published in Cancer Weekly, July 25th, 2006
Scientists writing in the International Journal of Oncology report, "Dendritic cells (DCs) have been shown to be potent in inducing cytotoxic T cell (CTL) response leading to the efficient anti-tumor effect in active immunotherapy. Myeloid DCs are conventionally generated from human peripheral blood monocytes in the presence of interleukin (IL)-4 and granulocyte/macrophage colony-stimulating factor (GM-CSF). Streptococcal preparation OK-432, which is known to be a multiple...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-07-25)
More Articles from Cancer Weekly
- Gynecologic Cancer
Psychoeducational intervention increased compliance with vaginal dilation - Non-Hodgkin Lymphoma
Non-Hodgkin lymphoma risk linked to cytokine polymorphisms in the Tb1/Th2 pathway - Oral Cancer
Oral cancer risk reduced with fruit and vegetable consumption - Prostate Cancer
Effect on prostate cancer treatment with IMRT by setup errors and organ motion assessed - Tumorigenesis
Acid-mediated tumor invasion model implicated altered glucose metabolism in cancer pathology - AIDS-Related Lymphoma
HIV score, IPI score and HAART affects survival in AIDS-related non-Hodgkin lymphoma - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
